Thomas J. Kelly | |
---|---|
Born | 1941 [1] |
Nationality | American |
Alma mater | Johns Hopkins University |
Awards | Louisa Gross Horwitz Prize of Columbia University [2] Alfred P. Sloan, Jr. Prize of the General Motors Cancer Research Foundation. [3] |
Scientific career | |
Fields | Molecular biology, biochemistry |
Institutions | Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center |
Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute, [4] [5] the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.
Before joining Sloan-Kettering in 2002, Kelly was professor and director of the Department of Molecular Biology [6] and Genetics at the Johns Hopkins University School of Medicine and was the founding director of the Johns Hopkins Institute for Basic Biomedical Sciences. [5] [7]
Kelly pioneered the study of DNA replication in eukaryotic cells by using DNA viruses as model systems. [8] His laboratory developed the first cell-free systems for studying the biochemistry of DNA replication in human cells, enabling the identification and functional characterization of components of the human replication machinery. [9]
In recognition of this work he received the 2004 Alfred P. Sloan, Jr. Prize of the General Motors Cancer Research Foundation [10] and the 2010 Louisa Gross Horwitz Prize of Columbia University. [11] [12]
Kelly earned a Ph.D. in biophysics in 1968 [13] and an M.D. in 1969.[ citation needed ] While a postdoctoral fellow with Hamilton O. Smith at the Johns Hopkins University School of Medicine during 1969-70, [14] Kelly determined the DNA sequences recognized by type II restriction enzymes, which subsequently became major tools in recombinant DNA research. [15] In 1970 he moved to the National Institutes of Health as a member of the United States Public Health Service and conducted research on the DNA viruses, adenovirus and SV40, which cause tumors in animals. [16] He joined the faculty in the Department of Microbiology at the Johns Hopkins University School of Medicine in 1972, where he began to exploit viruses as potentially powerful model systems for exploring the mechanisms of DNA replication in human cells. [17]
Using proteins derived from human cells, he and his colleagues developed the first cell-free DNA replication systems capable of duplicating the complete genomes of adenovirus and SV40. [18] The SV40 system proved to be a particularly useful system because SV40 relies largely on the cellular replication machinery for the duplication of its genome. Thus, biochemical analysis of the SV40 system made it possible to identify and functionally characterize proteins and enzymes that carry out the duplication of the chromosomal DNA in human cells. [19] In subsequent work Kelly and colleagues have shifted their focus from studying the machinery of DNA replication to the mechanism that controls it. Studying these mechanisms are essential for ensuring the accuracy of DNA replication during the cell cycle in human cells and in fission yeast (Schizosaccharomyces pombe), which is highly significant in understanding cancer. [20] [21] [22]
Since 2002, Kelly has been the director of the Sloan-Kettering Institute, where he has expanded or re-invigorated some of its laboratory research programs. [23] Kelly also led the establishment of the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, which provides a novel curriculum in basic and translational cancer biology leading to the Ph.D. degree. [24] [25]
Adenoviruses are medium-sized, nonenveloped viruses with an icosahedral nucleocapsid containing a double-stranded DNA genome. Their name derives from their initial isolation from human adenoids in 1953.
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
Polyomaviridae is a family of viruses whose natural hosts are primarily mammals and birds. As of 2020, there are six recognized genera and 117 species, five of which are unassigned to a genus. 14 species are known to infect humans, while others, such as Simian Virus 40, have been identified in humans to a lesser extent. Most of these viruses are very common and typically asymptomatic in most human populations studied. BK virus is associated with nephropathy in renal transplant and non-renal solid organ transplant patients, JC virus with progressive multifocal leukoencephalopathy, and Merkel cell virus with Merkel cell cancer.
SV40 is an abbreviation for simian vacuolating virus 40 or simian virus 40, a polyomavirus that is found in both monkeys and humans. Like other polyomaviruses, SV40 is a DNA virus that sometimes causes tumors in animals, but most often persists as a latent infection. SV40 has been widely studied as a model eukaryotic virus, leading to many early discoveries in eukaryotic DNA replication and transcription.
Human embryonic kidney 293 cells, also often referred to as HEK 293, HEK-293, 293 cells, or less precisely as HEK cells, are a specific immortalised cell line derived from a spontaneously miscarried or aborted fetus or human embryonic kidney cells grown in tissue culture taken from a female fetus in 1973.
An oncovirus or oncogenic virus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, when the term "oncornaviruses" was used to denote their RNA virus origin. With the letters "RNA" removed, it now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus". The vast majority of human and animal viruses do not cause cancer, probably because of longstanding co-evolution between the virus and its host. Oncoviruses have been important not only in epidemiology, but also in investigations of cell cycle control mechanisms such as the retinoblastoma protein.
James Edward Rothman is an American biochemist. He is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University, the Chairman of the Department of Cell Biology at Yale School of Medicine, and the Director of the Nanobiology Institute at the Yale West Campus. Rothman also concurrently serves as adjunct professor of physiology and cellular biophysics at Columbia University and a research professor at the UCL Queen Square Institute of Neurology, University College London.
SV40 large T antigen is a hexamer protein that is a dominant-acting oncoprotein derived from the polyomavirus SV40. TAg is capable of inducing malignant transformation of a variety of cell types. The transforming activity of TAg is due in large part to its perturbation of the retinoblastoma (pRb) and p53 tumor suppressor proteins. In addition, TAg binds to several other cellular factors, including the transcriptional co-activators p300 and CBP, which may contribute to its transformation function. Similar proteins from related viruses are known as large tumor antigen in general.
Yuan Chang is a Taiwanese-American virologist and pathologist who co-discovered together with her husband, Patrick S. Moore, the Kaposi's sarcoma-associated herpesvirus (KSHV) and Merkel cell polyomavirus, two of the seven known human oncoviruses.
Harald zur Hausen NAS EASA APS was a German virologist. He carried out research on cervical cancer and discovered the role of papilloma viruses in cervical cancer, for which he received the Nobel Prize in Physiology or Medicine in 2008. He was chairman of the German Cancer Research Center in Heidelberg.
Eugene O. "Gene" Major is a senior investigator at the National Institute of Neurological Disorders and Stroke (NINDS), a part of the United States National Institutes of Health (NIH). Major conducts research into the neurological diseases including progressive multifocal leukoencephalopathy (PML), caused by JC virus and often found in immunosuppressed patients such as those with HIV/AIDS. Major has published over 140 scientific articles and reviews in the peer-reviewed literature and has contributed to Fields Virology, a standard virology textbook.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Arnold Jay Levine, is an American molecular biologist. He was awarded the 1998 Louisa Gross Horwitz Prize for Biology or Biochemistry and was the first recipient of the Albany Medical Center Prize in Medicine and Biomedical Research in 2001 for his discovery of the tumor suppressor protein p53.
Bruce William Stillman, AO, FAA, FRS is a biochemist and cancer researcher who has served as the Director of Cold Spring Harbor Laboratory (CSHL) since 1994 and President since 2003. He also served as the Director of its NCI-designated Cancer Center for 25 years from 1992 to 2016. During his leadership, CSHL has been ranked as the No. 1 institution in molecular biology and genetics research by Thomson Reuters. Stillman's research focuses on how chromosomes are duplicated in human cells and in yeast Saccharomyces cerevisiae; the mechanisms that ensure accurate inheritance of genetic material from one generation to the next; and how missteps in this process lead to cancer. For his accomplishments, Stillman has received numerous awards, including the Alfred P. Sloan, Jr. Prize in 2004 and the 2010 Louisa Gross Horwitz Prize, both of which he shared with Thomas J. Kelly of Memorial Sloan-Kettering Cancer Center, as well as the 2019 Canada Gairdner International Award for biomedical research, which he shared with John Diffley.
Ed Harlow is an American molecular biologist.
Maurice Green was an American virologist. He is regarded as a pioneer in the study of animal viruses, in particular their role in cancer. Green founded the Institute of Molecular Virology at St. Louis University School of Medicine in the late 1950s, and later served as its chairman.
Scott William Lowe is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.
Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.
Wallace Prescott Rowe was an American virologist, known for his research on retroviruses and oncoviruses and as a co-discoverer of adenoviruses.
A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.
{{cite journal}}
: CS1 maint: multiple names: authors list (link){{cite journal}}
: CS1 maint: multiple names: authors list (link)